The significance of p53 and K-ras immunocytochemical staining in the diagnosis of malignant biliary obstruction by brush cytology during ERCP

Gut and Liver

Volumn 4, Issue 2, 2010, Pages 219-225

  Kim, Young Sup ^a   Kim, Ho Gak ^a   Han, Jimin ^a   Hur, Change Jae ^a   Kim, Byeong Suk ^a   Jung, Jin Tae ^a   Kwon, Joong Goo ^a   Kim, Eun Young ^a   Cho, Chang Ho ^a   Sohn, Yoon Kyung ^b  

^a Catholic University of Daegu   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Brush cytology; ERCP; Immunocytochemical stain; Malignant biliary obstruction

Indexed keywords

K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BILE DUCT OBSTRUCTION; CYTOLOGY; DIAGNOSTIC ACCURACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY;

EID: 77953547295     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.2.219     Document Type: Article

References (32)

1. Foutch PG, Kerr DM, Harlan JR, Manne RK, Kummet TD, Sanowski RA. Endoscopic retrograde wire-guided brush cytology for diagnosis of patients with malignant obstruction of the bile duct. Am J Gastroenterol 1990;85:791-795. (Pubitemid 20280923)
2. Foutch PG. Diagnosis of cancer by cytologic methods performed during ERCP. Gastrointest Endosc 1994;40:249-252.
3. Jailwala J, Fogel EL, Sherman S, et al. Triple-tissue sampling at ERCP in malignant biliary obstruction. Gastrointest Endosc 2000;51:383-390. (Pubitemid 30204754)
4. Bardales RH, Stanley MW, Simpson DD, et al. Diagnostic value of brush cytology in the diagnosis of duodenal, biliary, and ampullary neoplasms. Am J Clin Pathol 1998;109: 540-548.
5. de Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). Gastrointest Endosc 2002;56:720-730. (Pubitemid 36531709)
6. Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G. Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 1999;31:712-717.
7. Farrell RJ, Jain AK, Brandwein SL, Wang H, Chuttani R, Pleskow DK. The combination of stricture dilation, endoscopic needle aspiration, and biliary brushings significantly improves diagnostic yield from malignant bile duct strictures. Gastrointest Endosc 2001;54:587-594. (Pubitemid 33666030)
8. Fogel EL, deBellis M, McHenry L, et al. Effectiveness of a new long cytology brush in the evaluation of malignant biliary obstruction: a prospective study. Gastrointest Endosc 2006;63:71-77.
9. Lee JG, Leung JW, Cotton PB, Layfield LJ, Mannon PJ. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1995;42:317-320.
10. Sturm PD, Rauws EA, Hruban RH, et al. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis. Clin Cancer Res 1999;5:629-635.
11. Van Laethem JL, Bourgeois V, Parma J, et al. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc 1998;47:479-485. (Pubitemid 28287566)
12. Levi S, Urbano-Ispizua A, Gill R, et al. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-3502.
13. Apple SK, Hecht JR, Novak JM, Nieberg RK, Rosenthal DL, Grody WW. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears. Am J Clin Pathol 1996;105:321-326.
14. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 1994;74:1542-1545. (Pubitemid 24302972)
15. DiGiuseppe JA, Hruban RH, Goodman SN, et al. Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 1994;101:684-688. (Pubitemid 24169297)
16. Ishimaru S, Itoh M, Hanada K, Tsuchida A, Iwao T, Kajiyama G. Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 1996;77:2233-2239. (Pubitemid 26162414)
17. Iwao T, Hanada K, Tsuchida A, Hirata M, Eguchi N, Kajiyama G. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations. Cancer 1998;82:1487-1494. (Pubitemid 28164994)
18. Tascilar M, Sturm PD, Caspers E, et al. Diagnostic p53 immunostaining of endobiliary brush cytology: preoperative cytology compared with the surgical specimen. Cancer 1999;87:306-311. (Pubitemid 29503486)
19. Stewart CJ, Burke GM. Value of p53 immunostaining in pancreatico-biliary brush cytology specimens. Diagn Cytopathol 2000;23:308-313.
20. Iwao T, Tsuchida A, Hanada K, Eguchi N, Kajiyama G, Shimamoto F. Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas. Cancer 1997;81:163-171. (Pubitemid 28275307)
21. Venu RP, Geenen JE, Kini M, et al. Endoscopic retrograde brush cytology. A new technique. Gastroenterology 1990; 99:1475-1479.
22. Osnes M, Serck-Hanssen A, Myren J. Endoscopic retrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol 1975;10:829-831.
23. Foutch PG, Harlan JR, Kerr D, Sanowski RA. Wire-guided brush cytology: a new endoscopic method for diagnosis of bile duct cancer. Gastrointest Endosc 1989;35:243-247. (Pubitemid 19164893)
24. Ryan ME. Cytologic brushings of ductal lesions during ERCP. Gastrointest Endosc 1991;37:139-142.
25. Mahmoudi N, Enns R, Amar J, AlAli J, Lam E, Telford J. Biliary brush cytology: factors associated with positive yields on biliary brush cytology. World J Gastroenterol 2008;14:569-573. (Pubitemid 351320823)
26. Lee JG. Brush cytology and the diagnosis of pancreaticobiliary malignancy during ERCP. Gastrointest Endosc 2006;63:78-80. (Pubitemid 41827781)
27. Dergham ST, Dugan MC, Kucway R, et al. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. Int J Pancreatol 1997;21:127-143. (Pubitemid 27278611)
28. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995;22:774-779.
29. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-1153. (Pubitemid 24294578)
30. Wang Y, Yamaguchi Y, Watanabe H, Ohtsubo K, Wakabayashi T, Sawabu N. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation. J Gastroenterol 2002;37:831-839. (Pubitemid 35390303)
31. Pugliese V, Pujic N, Saccomanno S, et al. Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and K-ras-2 codon 12 molecular analysis in 47 cases. Gastrointest Endosc 2001;54:595-599. (Pubitemid 33666031)
32. Vadmal MS, Byrne-Semmelmeier S, Smilari TF, Hajdu SI. Biliary tract brush cytology. Acta Cytol 2000;44:533-538.